Speciality: Oncology
Description:
A warm welcome to all medical professionals joining us for this insightful session: "Understanding the Evolution in Lung Cancer - An Initiative from Manipal Hospitals." Lung cancer treatment has undergone a remarkable transformation in recent years, moving from broad-spectrum therapies to highly precise, personalized approaches. Manipal Hospitals, at the forefront of medical innovation, is dedicated to integrating these advancements to offer cutting-edge care, improving patient outcomes and quality of life. This session, featuring renowned expert Dr. Lalit Sharma, will delve into the pivotal shifts in diagnostics, targeted therapies, immunotherapies, and surgical techniques that are redefining lung cancer management.
The journey of lung cancer treatment has seen significant breakthroughs, driven by a deeper understanding of the disease's molecular landscape. From early detection methods to the development of novel drugs that target specific genetic mutations, the evolution has been profound. Dr. Lalit Sharma will share his expertise on how these advancements, including precision medicine and innovative surgical procedures, are being effectively implemented at Manipal Hospitals. This initiative underscores Manipal's commitment to patient-centric care, ensuring that individuals receive tailored treatments based on their unique tumor characteristics, leading to more effective and less toxic interventions.
This webinar offers a comprehensive overview of the current best practices and future directions in lung cancer therapy. Attendees will gain valuable knowledge on the latest research, clinical trials, and multidisciplinary approaches that are crucial for optimizing patient care. Tune in to this session by Dr. Lalit Sharma and Manipal Hospitals to enhance your understanding of the dynamic field of lung cancer treatment and stay informed about the continuous progress in combating this challenging disease.
See More Webinars @ Hidoc Webinars
1.
Doctors say lung cancer is still the deadliest cancer, but hope is growing
2.
Child Death Rates Are Rising in the U. s. ; Water Beads Warning; Cancer Studies Retracted.
3.
FDA Leaders Explain Their Choice Regarding Cancer Risk Warning in CAR-T Investigation.
4.
The FDA has approved momelotinib for use in myelofibrosis patients who also have anemia.
5.
Virtual Reality Travel Reduces Cancer Pain.
1.
Clinical Decision-Making in Oligometastatic Cancer: A Case-Based Perspective
2.
Iron Homeostasis Throughout the Female Lifespan
3.
The Benefits and Side Effects of Vidaza Syndrome
4.
Holistic Oncology: Advancing Survivorship, Nursing, and Innovative Cancer Care Models
5.
Exercise Rehabilitation in Hematologic Disease Survivorship
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
2.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V
3.
Efficient Management of First line ALK-rearranged NSCLC - Part IV
4.
A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
5.
Preventing Blood Clots: The Importance of Venous Thromboembolism Management
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation